RE:RE:RE:RE:RE:RE:RE:Building expectations If anyone here thinks things are going to change just because we talked about voting out a board member or two, you are sadly mistaken.
scarlet1967 wrote: This is from current website, how difficult is it to update the freaking pipeline in timely manner?
Theratechnologies intends to submit its Phase 3 study protocol to the United States Food and Drug Administration (FDA) and the European regulatory agencies in the fourth quarter of 2020. Subject to approval from the regulatory agencies, the enrollment of patients is planned for the first quarter of 2021.